Cite

HARVARD Citation

    Kaabak, M. et al. (2018). A prospective randomized, controlled trial of eculizumab to prevent ischemia‐reperfusion injury in pediatric kidney transplantation. Pediatric transplantation. p. n/a. [Online]. 
  
Back to record